"Breast hypertrophy" from_date:2012

[Reducing mammaplasty for the treatment of patients with breast hypertrophy and chronic dorsalgia] [Reducing mammaplasty for the treatment of patients with breast hypertrophy and chronic dorsalgia ] ..

Cost-utility analysis of breast reduction surgery for women with symptomatic breast hypertrophy. To assess the cost-effectiveness of breast reduction surgery for women with symptomatic breast hypertrophy in Australia. Cost-utility analysis of data from a prospective cohort study. Adult women with symptomatic breast hypertrophy assessed for bilateral breast reduction at the Flinders Medical Centre, a public tertiary hospital in Adelaide, April 2007 - February 2018. The control group included women with breast hypertrophy who had not undergone surgery. Health care costs (for the surgical admission and other related hospital costs within 12 months of surgery) and SF-6D utility scores (measure of health-related quality of life) were used to calculate incremental costs per quality-adjusted

Virginal breast hypertrophy in a patient with Beckwith–Wiedemann syndrome Virginal breast hypertrophy is a multidisciplinary condition including surgical, pediatric, and endocrine/gynecological disciplines, and its successful diagnosis and management requires complex, team approach.

Juvenile Breast Hypertrophy: A Successful Breast Reduction of 14.9% Body Weight without Recurrence in a 5-Year Follow-Up Juvenile hypertrophy of the breast (JHB) is a rare and relentless disease affecting women in the peripubertal period. We present a 13-year-old girl with massive bilateral JHB, successfully treated with a breast reduction and free nipple graft technique. A total of 7300 grams

Title: Clinical and Surgical Outcomes of Virginal Breast Hypertrophy (VBH) in Adolescent Females: A Systematic Review of Case Reports. PROSPERO International prospective register of systematic reviews Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant

Reduction of Breast Hypertrophy by Means of Coelioscopique Surgery The objective of this interventional study is based on the hypothesis that coelioscopique surgery could be used to reduce breast hypertrophy.This study can be expected to scientifically validate the use of laparoscopic surgery to obtain a clinical result in the context of reduction of medium volume breast hypertrophy. Breast

Sexual Function and Depression Outcomes Among Breast Hypertrophy Patients Undergoing Reduction Mammaplasty: A Randomized Controlled Trial. The breasts are important symbols of femininity and sensuality. Alterations such as breast hypertrophy can affect several aspects of women's quality of life. Breast hypertrophy is a prevalent health condition, which is treated by reduction mammaplasty . The aim of the present study was to assess sexual function and depression outcomes among breast hypertrophy patients undergoing reduction mammaplasty. Sixty breast hypertrophy patients were randomly allocated to a control group (CG) (n = 30) or a breast reduction group (BRG) (n = 30). The patients in the CG were assessed at the first appointment as well as 3 and 6 months later. The patients in the BRG

Postural control in women with breast hypertrophy: Postural control in breast hypertrophy The consequences of breast hypertrophy have been described based on the alteration of body mass distribution, leading to an impact on psychological and physical aspects. The principles of motor control suggest that breast hypertrophy can lead to sensorimotor alterations and the impairment of body balance due to postural misalignment. The aim of this study is to evaluate the postural control of women with breast hypertrophy under different sensory information conditions. This cross-sectional study included 14 women with breast hypertrophy and 14 without breast hypertrophy, and the mean ages of the groups were 39 ± 15 years and 39 ± 16 years, respectively. A force platform was used to assess

methodology). Evidence-based recommendations were made and strength was determined based on the level of evidence and the assessment of benefits and harms.Reduction mammaplasty is a procedure performed for symptomatic breast hypertrophy in more than 100,000 patients per year.1 There is an extensive body of evidence demonstrating the efficacy of reduction mammaplasty in reducing both physical and psychological symptoms in patients with symptomatic breast hypertrophy.2–9In 2012, the American Society of Plastic Surgeons published the first guideline on reduction mammaplasty.10 The previous guideline recommendations included resection volume, complications, antibiotics, use of drain, liposuction, and symptom reduction. In summary, resection volume was not correlated with symptom relief (grade B evidence

for and potential mechanisms underlying macromastia-related headache. A literature search was performed in PubMed Medline using concepts "breast hypertrophy," "macromastia," "headache," "migraine," "breast reduction," and "reduction mammoplasty" excluding limits on age, language, publication date, or study type. Supplemental literature searches were performed to provide a comprehensive understanding of potential

for treatment of breast hypertrophy; the same surgical technique was used for all patients. In each patient, 1 breast was assigned to a control group and the other to an experimental group. The periareolar dermis release was performed in the experimental group (39 breasts). Pressure sensitivity was tested with Semmes-Weinstein monofilaments on the papilla and at 4 specific points of the areola

after reduction mammaplasty. The authors conducted a randomized trial of noninferiority, with two parallel groups, with triple blinding. The participants were 124 women with breast hypertrophy, with reduction mammaplasty already scheduled, selected consecutively. All patients underwent reduction mammaplasty, performed by the same surgical team, using the superomedial pedicle technique for ascending

Does breast reduction surgery improve health-related quality of life? A prospective cohort study in Australian women. To assess the health burden of breast hypertrophy and the comparative effectiveness of breast reduction surgery in improving health-related quality of life. Prospective cohort study. A major public tertiary care hospital in Australia. Women with symptomatic breast hypertrophy who underwent breast reduction surgery were followed for 12 months. A comparison control cohort comprised women with breast hypertrophy who did not undergo surgery. Bilateral breast reduction surgery for women in the surgical cohort. The primary outcome measure was health-related quality of life measured preoperatively and at 3, 6 and 12 months postoperatively using the Short Form-36 (SF-36) questionnaire

damage. This study aimed to retrospectively analyse the operative performance of a novel low-thermal plasma dissection device (pulsed electron avalanche knife-PEAK PlasmaBlade™) compared with traditional electrosurgery. Twenty patients with breast hypertrophy were randomly treated with PEAK PlasmaBlade™ on one breast and conventional electrosurgery on the other. Primary outcome measures were resection

disease is progressive, becoming more noticeable with duration of disease and length of treatment. The disfigurement can be distressing and stigmatising.The following physical changes may occur:Lipohypertrophy * Development of a 'buffalo hump' or increased dorso-cervical fat pad. * Expansion of neck circumference by up to 10 cm. * Breast hypertrophy. * Central truncal adiposity caused by visceral fat

were prospectively evaluated. All patients with an MRI-detected additional lesion underwent second-look US, and if occult, contrast-enhanced MRI in supine position was performed for US and MRI co-registration. For patients with breast hypertrophy, MRI-guided biopsy was performed directly. Pathologic examination was the standard of reference. One-way ANOVA and chi-square tests were used. In 490 MRI

Outcomes of Breast Reduction Surgery Using the BREAST-Q: A Prospective Study and Comparison with Normative Data. This study aimed to assess breast-related satisfaction and well-being in women with breast hypertrophy before and after breast reduction surgery, and to compare these scores with Australian general population norms, using the BREAST-Q Reduction module. A prospective cohort study postoperatively. Statistically significant improvements were found following surgery in Satisfaction with Breasts, Psychosocial Well-being, Sexual Well-being, and Physical Well-being. In comparison with normative data, patients with breast hypertrophy had significantly lower scores preoperatively, with scores significantly increasing postoperatively to levels representative of the general population